Lumicell Revenue and Competitors

Claim your profile

Boston, MA USA



Total Funding

Estimated Revenue & Valuation

  • Lumicell's estimated annual revenue is currently $8.5M per year.(i)
  • Lumicell received $28.7M in venture funding in December 2017.
  • Lumicell's estimated revenue per employee is $152,393
  • Lumicell's total funding is $33M.

Employee Data

  • Lumicell has 56 Employees.(i)
  • Lumicell grew their employee count by 14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Lumicell is a leader in the field of image-guided cancer surgery. Lumicell technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett's Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Lumicell News

2022-03-22 - Clinical Data on Lumicell's Direct Visualization System to Be ...

Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve...

2019-09-12 - Innoblative taps ex-Lumicell chief Londy for CEO | Personnel ...

Innoblative Designs last week named former Lumicell chief executive Kelly Londy as its new CEO. Apart from her two-year stint at the Lumicell ...

2019-08-17 - Lumicell closes enrollment of feasibility trial

Lumicell said it completed enrollment in a Phase C feasibility clinical trial for its intraoperative breast cancer imaging system. The Newton, Mass ...

2019-06-19 - Lumicell Technology Improves Efficiency of Mesothelioma ...

Lumicell- Experts are testing a new innovative imaging technology at Massachusetts General Hospital. The imaging technology can enhance ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Lumicell Funding

DateAmountRoundLead InvestorsReference
2017-12-08$28.7MCLaunch CapitalArticle